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Background. Alpha II antiplasmin is a protein involved in the inhibition of ﬁbrinolysis. A deﬁciency in this protein leads to
increased hemorrhage. It is inherited in anautosomalrecessive fashion.Case.30-year-old Gravida 1, Para 0, presented forprenatal
care with her ﬁrst and subsequently her second pregnancy. Her medical history was signiﬁcant for a known deﬁciency in alpha
II antiplasmin. Her ﬁrst and second pregnancies were complicated by nonobstetrical hemorrhage requiring transfusions and
severe preeclampsia requiring preterm deliveries. Conclusion. Alpha II antiplasmin deﬁciency resulted in multiple episodes of
nonobstetrical hemorrhages requiring transfusion and ultimately preterm deliveries due to severe preeclampsia. Both infants and
motherhad a good outcome. The presence ofthis disorder mayrequire a multidisciplinary team approach involvingobstetricians,
pediatricians, and hematologists.Precis. Alpha II antiplasmindeﬁciency is a rare autosomalrecessive disorder leading to increased
ﬁbrinolysis and hemorrhage. We present a case report of a pregnancy complicated by this disorder.
1.Introduction
Alpha II antiplasmin is a glycoprotein synthesized by the
liver. Itis present intwo distinct forms: plasminogen binding
and nonplasminogen binding. 20% of the plasminogen
binding form is covalently linked to ﬁbrin clots and renders
them more resistant to lyses. It is inherited in an autosomal
recessive fashion. A deﬁciency in its production allows the
ﬁbrin clotstolyse anddissolve prematurelyresulting in hem-
orrhage. It is also a strong inhibitor of plasmin, an enzyme
directly involved in ﬁbrinolysis [1].
Plasmin is involved in the cleavage of extracellular vas-
cular endothelial growth factor. A deﬁciency in its inhibitor
(alpha II antiplasmin) has been shown in vitro mice studies
to increase the mortality from an acute myocardial in-
farction. VEGF has been shown to increase the vascular per-
meability in ischemic tissue; its overproduction results in
pulmonary edema and increased mortality. Elevated levels
of VEGF have been associated with increased incidence of
preeclampsia [2].
2.Case
Our patient ﬁrst presented to our service at 10-week
gestation. She was a 30-year-old Caucasian female Gravida 1,
Para zero. She had been diagnosed with alpha II antiplasmin
deﬁciency with a level 50% normal due to several episodes
of severe hematuria secondary to nephrolithiasis. She had
received multiple blood transfusions in her adolescence due
to the severity of these bleeds. Her brother had been diag-
nosed with alpha II antiplasmin deﬁciency and Von Wille-
brand’sdisease;thepatienthadtestednegativeforVonWille-
brand’s disease. Consanguinity was denied by the patient.
Her past surgical history was signiﬁcant for a laparo-
scopic excision of a benign ovarian cyst and a tonsillectomy.
Shewas single, nonsmoker, and nondrinkerand deniedillicit
drug use. Her family history was signiﬁcant for the brother
with the bleeding diathesis. She also had a cousin diagnosed
with Trisomy 21. Her father and her maternal and paternal
grandmothers suﬀered from hypertension.
With her ﬁrst pregnancy, she presented at 10-week ges-
tation with recurrent nephrolithiasis and hematuria. Her2 Obstetrics and Gynecology International
hemoglobinwas9.6;shewascontrolledwithintravenousﬂu-
ids and narcotics for pain control; she was discharged after 5
days and represented one week later with similar complaints.
Nephrologywas consulted;24-hoururine revealedexcess
urine calcium excretion of 582mg/day. She was begun on
amiloride 5mg daily to control her hypercalcuria. She was
readmitted at 17-week gestation with frank hematuria and
passage of large clots of blood in her urine and severe back
pain. Her hemoglobin remained stable at 9.6; conservative
management continued. A PICC line was required to main-
tain intravenous access. She was discharged after several days
and remained as an outpatient until 25-week gestation when
she presented with heavy vaginal bleeding that soaked at
least 4 peripads. She received 2-unit fresh frozen plasma
and her bleeding resolved. A negative fetal cell stain and
normal ultrasound revealed an appropriately sized infant
with a normally implanted placenta. She received a course
of betamethasone due to preterm status. She was observed
for several days and was discharged home with the diagnosis
of a stable placenta abruption. Close outpatient follow-
up with serial nonstress tests and biophysical proﬁles was
initiated. She remained stable until 32-week gestation when
recurrent vaginal bleeding developed. She was hospitalized
and at 34-week gestation oligohydramnios and new onset
hypertension developed. She was ultimately diagnosed with
severepreeclampsiabybloodpressure criteria;shewasbegun
on magnesium sulfate for seizure prophylaxis and cervidil
and pitocin induction. She had a spontaneous vaginal deliv-
ery complicated by postpartum hemorrhage that responded
to fresh frozen plasma. Her infant was a female weighing
1760 grams with agars 6 at 1 minute and 8 at 5 minutes.
Her prenatal course was complicated by hyermagnesemia,
hyperbilirubinemia,andrespiratory depression;sherequired
transient oxygensupport and was discharged on day oflife 8.
Our patient represented with her second pregnancy at
8-week gestation. She had required hospitalization several
times in the interim due to hematuria and nose bleeds. Her
second pregnancy was complicated by fetal bilateral choroid
plexus cysts and recurrent migraines. She declined genetic
amniocentesis and remained an outpatient until 30-week
gestation. She presented with massive nasal bleeding requir-
ing transfusion of fresh frozen plasma and 2-unit packed
red blood cells. She was also begun on aminocaprioc acid 5
gramsevery6hoursuntilherbleedingresolved. Sherequired
surgical interventionby EENT. Shedevelopedelevated blood
pressure and oligohydramnios requiring induction of labor
and magnesium sulfate prophylaxis and delivered at 33-week
gestation. She had received betamethasone prior to delivery.
She delivered a viable male weighing 1980 grams with agars
9 at one minute and 9 at 5 minutes. His neonatal course was
complicated by apnea, feeding diﬃculties, respiratory dis-
tress syndrome, and hyperbilirubinemia. He was discharged
on day of life 21.
3.Discussion
Alpha II antiplasmin deﬁciency is a rare autosomal recessive
disorder leading to increased lyses of ﬁbrin clots and in-
creased risk hemorrhage. When blood clots, multiple factors
including plasminogen are bound to ﬁbrin: this complex
leads to plasminogen activation and conversion to plasmin.
Plasmin digests the ﬁbrin component of the thrombus.
Inhibition of this process is achieved mainly through several
inhibitors including plasminogen activator inhibitor and
alpha II antiplasmin inhibitor. The plasmin and alpha II
antiplasmin form a stable, inactive complex preventing
further lyses of ﬁbrin. Lack of alpha II antiplasmin will lead
to increased levels of plasmin and increased ﬁbrinolysis and
hemorrhage.
Our patient experienced multiple episodes of bleeding;
control required use of both fresh frozen plasma and ami-
nocaprioc acid. Fresh frozen plasma is eﬀective in control of
bleeding by replacing the ﬁbrinogen and allowing normal
clot formation to continue. Aminocaprioc acid inhibits ﬁb-
rinolysis of the ﬁbrin plug. Contra indications include sensi-
tivity to drug, disseminated intravascular coagulopathy, and
severe renal, hepatic, or cardiac disease. 33% of patients will
experience signiﬁcant gastrointestinal side eﬀects such as
nausea, abdominal pain, and diarrhea. It is considered an
FDA class C drug in pregnancy.
Levels of the alpha II antiplasmin-plasmin complex has
been shown to be elevated in acute stroke and myocardial
infarction. Lack of alpha 2 antiplasmin in mice has been
shown to increase the mortality after an acute myocardial
infarction [3]. Alpha 2 antiplasmin is essential in the
regulation of circulating vascular endothelial growth factor;
a deﬁciency is associated with increased levels of VEGF.
Increased levels of VEGF post myocardial infarction appears
associated with increased levels of cell damage and mortality
[2]. VEGF has recently been shown to be involved in
the placental implantation process; elevated levels in early
pregnancy have been associated with increased risk of devel-
oping preeclampsia. Our patient developed preterm severe
preeclampsia with both her pregnancies. The elevated level
of VEGF resulting from her alpha II antiplasmin deﬁciency
may have been involved in this process. Unfortunately, her
level of VEGF was not determined at the time of her
pregnancy. Further areas of study may involve determining
the level of alpha II antiplasmin in the ﬁrst trimester of
pregnancy to determine if higher levels are associated with
an increased risk of developing preeclampsia [4]. If higher
levels are discovered, implementation of close follow-up
and observation of increased edema and increased vascular
resistance may allow the prevention of preeclampsia.
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